Status:
COMPLETED
Nebulized Epinephrine vs. Salbutamol in Bronchiolitis Among Children
Lead Sponsor:
Makassed General Hospital
Conditions:
Respiratory Distress Score
Eligibility:
All Genders
1-24 years
Phase:
NA
Brief Summary
Acute bronchiolitis, mostly secondary to infection due to Respiratory syncytial virus (RSV) is very common in infants under two years old. It is usually benign. However, the dyspnea it causes is a big...
Detailed Description
The objective of this study is to determine if nebulized epinephrine is more efficacious than nebulized salbutamol in all hospitalized children (1 month to 24 months) in treatment of bronchiolitis. A ...
Eligibility Criteria
Inclusion
- Children diagnosed with acute bronchiolitis.
Exclusion
- Children with congenital heart disease or
- chronic lung diseases
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03814954
Start Date
January 1 2019
End Date
August 31 2021
Last Update
August 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Makassed General Hospital
Beirut, Lebanon